Mette Villingshøj, Biomedical Laboratory Scientist, MPH
Title: Technician, Deputy Head
Email: mette.villingshoj@rh.regionh.dk.jpg)
Phone: (+45) 35 45 63 29
Fax: (+45) 35 45 63 01
Date of Birth:
June 8th, 1968
Current Position:
Deputy Head, Biomedical Laboratory Scientist
Education:
2000-2003: Master of Public Health, University of Copenhagen, Denmark
1998-2000: Studies in Theory of Education, University of Copenhagen, Denmark
1988-1990: Biomedical Laboratory Scientist, Frederiksberg Hospital, Denmark
1985-1987: High School, Espergærde Gymnasium, Denmark
Professional Experiences:
2005-2011: Deputy Head, Biomedical Laboratory Scientist, Department of Radiation Biology, Copenhagen University Hospital, Denmark
2002-2005: Biomedical Laboratory Scientist, Department of Radiation Biology, Copenhagen University Hospital, Denmark
2002-2005: Master student, Institute of Cancer Epidemiology, Danish Cancer Society, Copen- hagen, Denmark
1998-2002: Biomedical Laboratory Scientist, Department of Radiation Biology, Copenhagen University Hospital, Denmark
1996-1998: Biomedical Laboratory Scientist, Coloplast Research, Humlebaek, Denmark 1991-1995: Biomedical Laboratory Scientist, Finsen Laboratory, Copenhagen University Hos-
pital, Denmark
Conferences and Meetings
Oral Presentations
2004: Villingshoj M, Ross L, Thomsen BL, Johansen C. Influence of changes in the social network on survival among patients with colorectal cancer. 7th World Congress of Psycho-Oncology, Copenhagen, Denmark
Poster Presentations
2007: Villingshoj M, Andersen P, Stockhausen MT, Ottesen L, Poulsen HS. Improved response by co-targeting EGFR/EGFRvIII and c-Src. American Association for Cancer Research, Annual Meeting 2007, Los Angeles, USA
Awards
2007: Awarded “Rigshospitalets Biomedical Laboratory Scientist Award” at Rigshospitalet, Copenhagen, Denmark
Publications with peer-review
Pedersen MW, Pedersen N, Damstrup L, Villingshøj M, Sonder SU, Rieneck K, Bovin LF, Spang-Thomsen M, Poulsen HS. Analysis of the epidemal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation. J Cell Biochem. 2005 Oct 1;96(2):412-27.
Villingshøj M, Ross L, Thomsen BL, Johansen C. Does marital status and altered contact with the social network predict colorectal cancer survival? Eur J Cancer. 2006 Nov;42(17):3022-7.
Spindler KL, Olsen DA, Nielsen JN, Brandslund I, Poulsen HS, Villingshøj M, Jakobsen A. Lack of the type III epidermal growth factor receptor mutation in colorectal cancer. Anticancer Res. 2006 Nov-Dec;26(6C):4889-93.
Andersen P, Pedersen MW, Woetmann A, Villingshøj M, Stockhausen MT, Odum N, Poulsen HS. EGFR induces expression of IRF-1 via Stat1 and Stat3 activation leading to growth arrest of human cancer cells. Int J Cancer. 2008 Jan 15;122(2):342-9.
Andersen P, Villingshøj M, Poulsen HS, Stockhausen MT. Improved response by co-targeting EGFR/EGFRvIII and Src family kinases in human cancer cells. Cancer Invest. 2009 Feb;27(2):178-83.
Stockhausen MT, Broholm H, Villingshøj M, Kirchhoff M, Gerdes T, Kristoffersen K, Kosteljanetz 14 M, Spang-Thomsen M, and Poulsen HS: Maintenance of EGFR and EGFRvIII expression in an in vivo and in vitro model of human glioblastoma multiforme. Exp Cell Res. 2011 Jul 1;317(11):1513-26.